| Date Filed | Type | Description |
| 10/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/27/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 09/27/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 08/25/2023 |
4
| Farfel Gail M (CEO) has filed a Form 4 on ProMIS Neurosciences Inc.|
Txns:
| Granted 53,192 shares
@ $0
Granted 53,192 options to buy
@ $1.75, valued at
$93.1k
|
|
| 08/25/2023 |
4
| Kirwin Patrick D. (Director) has filed a Form 4 on ProMIS Neurosciences Inc.|
Txns:
| Granted 11,000 shares
@ $0
Granted 11,000 options to buy
@ $1.75, valued at
$19.3k
|
|
| 08/25/2023 |
4
| Malenfant Gavin T. (COO) has filed a Form 4 on ProMIS Neurosciences Inc.|
Txns:
| Granted 2,660 shares
@ $0
Granted 2,660 options to buy
@ $1.75, valued at
$4.7k
|
|
| 08/25/2023 |
4
| Cashman Neil (Chief Scientific Officer) has filed a Form 4 on ProMIS Neurosciences Inc.|
Txns:
| Granted 10,643 shares
@ $0
Granted 10,643 options to buy
@ $1.75, valued at
$18.6k
|
|
| 08/25/2023 |
4
| Milbury Max A. (Principal Accounting Officer) has filed a Form 4 on ProMIS Neurosciences Inc.|
Txns:
| Granted 13,297 shares
@ $0
Granted 13,297 options to buy
@ $1.75, valued at
$23.3k
|
|
| 08/22/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/22/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 08/14/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/14/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/14/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/14/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 07/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/30/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/30/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 06/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/18/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/15/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/08/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/27/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/27/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/03/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/17/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/16/2023 |
3
| Kaplan Johanne (Chief Development Officer) has filed a Form 3 on ProMIS Neurosciences Inc. |
|